Variant to Gene Mapping to Discover New Targets for Immune Tolerance.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Mehra P;Mehra P; Wells AD; Wells AD; Wells AD
  • Source:
    Frontiers in immunology [Front Immunol] 2021 Apr 15; Vol. 12, pp. 633219. Date of Electronic Publication: 2021 Apr 15 (Print Publication: 2021).
  • Publication Type:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
    • Publication Information:
      Original Publication: [Lausanne : Frontiers Research Foundation]
    • Subject Terms:
    • Abstract:
      The breakdown of immunological tolerance leads to autoimmune disease, and the mechanisms that maintain self-tolerance, especially in humans, are not fully understood. Genome-wide association studies (GWAS) have identified hundreds of human genetic loci statistically linked to autoimmune disease risk, and epigenetic modifications of DNA and chromatin at these loci have been associated with autoimmune disease risk. Because the vast majority of these signals are located far from genes, identifying causal variants, and their functional consequences on the correct effector genes, has been challenging. These limitations have hampered the translation of GWAS findings into novel drug targets and clinical interventions, but recent advances in understanding the spatial organization of the genome in the nucleus have offered mechanistic insights into gene regulation and answers to questions left open by GWAS. Here we discuss the potential for 'variant-to-gene mapping' approaches that integrate GWAS with 3D functional genomic data to identify human genes involved in the maintenance of tolerance.
      Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
      (Copyright © 2021 Mehra and Wells.)
    • References:
      Nat Commun. 2020 Jul 3;11(1):3294. (PMID: 32620744)
      Nat Immunol. 2021 Apr 8;:. (PMID: 33833438)
      Hum Mol Genet. 1996 Jul;5(7):1075-80. (PMID: 8817351)
      Arthritis Res Ther. 2018 Sep 29;20(1):216. (PMID: 30268153)
      PLoS One. 2016 Jul 28;11(7):e0159565. (PMID: 27467597)
      Cell. 2019 Sep 5;178(6):1493-1508.e20. (PMID: 31474370)
      Cell. 2016 Mar 10;164(6):1110-1121. (PMID: 26967279)
      PLoS One. 2016 Nov 11;11(11):e0166312. (PMID: 27835693)
      Cell. 2018 Nov 29;175(6):1701-1715.e16. (PMID: 30449622)
      Nucleic Acids Res. 2013 Jul;41(Web Server issue):W150-8. (PMID: 23723249)
      Immunol Rev. 2014 May;259(1):192-205. (PMID: 24712467)
      Am J Hum Genet. 2017 Jul 6;101(1):5-22. (PMID: 28686856)
      Ann Rheum Dis. 2016 Jul;75(7):1407-15. (PMID: 26324847)
      J Biol Chem. 2012 Jun 29;287(27):22900-9. (PMID: 22584578)
      Arthritis Res Ther. 2016 Dec 1;18(1):281. (PMID: 27906046)
      Clin Epigenetics. 2019 Feb 26;11(1):34. (PMID: 30808407)
      Sci Rep. 2019 Feb 19;9(1):2302. (PMID: 30783191)
      Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14751-6. (PMID: 20679229)
      Front Genet. 2014 Feb 18;5:39. (PMID: 24600475)
      Nat Commun. 2018 Sep 5;9(1):3594. (PMID: 30185805)
      J Clin Invest. 2015 Jun;125(6):2234-41. (PMID: 26030227)
      Sci Transl Med. 2015 Nov 25;7(315):315ra189. (PMID: 26606968)
      Nat Genet. 2015 Apr;47(4):381-6. (PMID: 25751624)
      Nat Immunol. 2018 Dec;19(12):1391-1402. (PMID: 30374130)
      Nat Immunol. 2017 Jul 19;18(8):832-842. (PMID: 28722725)
      Nat Genet. 2019 Oct;51(10):1486-1493. (PMID: 31548716)
      J Biomed Biotechnol. 2011;2011:432595. (PMID: 22028588)
      Hum Mol Genet. 2015 Jan 15;24(2):397-409. (PMID: 25190711)
      Immunity. 1997 Aug;7(2):255-71. (PMID: 9285410)
      Nat Genet. 2013 Feb;45(2):124-30. (PMID: 23263488)
      Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14875-9. (PMID: 9843983)
      Am J Hum Genet. 2005 Dec;77(6):1044-60. (PMID: 16380915)
      Cells. 2019 Aug 22;8(9):. (PMID: 31443448)
      Cell. 2016 Nov 17;167(5):1369-1384.e19. (PMID: 27863249)
      Nat Commun. 2020 Jun 3;11(1):2781. (PMID: 32493900)
      J Autoimmun. 2016 Apr;68:62-74. (PMID: 26898941)
      J Clin Invest. 2020 Jan 2;130(1):203-213. (PMID: 31573979)
      Nat Clin Pract Rheumatol. 2007 Sep;3(9):521-7. (PMID: 17762851)
      Nat Genet. 2017 Jan;49(1):139-145. (PMID: 27918533)
      Annu Rev Immunol. 2012;30:707-31. (PMID: 22224760)
      Am J Hum Genet. 2004 Aug;75(2):330-7. (PMID: 15208781)
      Nat Immunol. 2018 Jul;19(7):665-673. (PMID: 29925983)
      Nat Commun. 2018 Sep 28;9(1):3973. (PMID: 30266981)
      Nature. 2013 Sep 26;501(7468):506-11. (PMID: 24037378)
      Cell. 2016 Jun 2;165(6):1519-1529. (PMID: 27259153)
      Am J Hum Genet. 1984 Sep;36(5):1015-23. (PMID: 6594040)
      JCI Insight. 2020 Sep 3;5(17):. (PMID: 32879140)
      Arthritis Rheumatol. 2015 Jul;67(7):1966-77. (PMID: 25833190)
      PLoS Genet. 2017 Feb 10;13(2):e1006587. (PMID: 28187197)
      Arthritis Rheum. 2003 Jul;48(7):1948-55. (PMID: 12847689)
      Cell. 1991 Apr 19;65(2):305-17. (PMID: 1901764)
      Immunity. 2018 Oct 16;49(4):725-739.e6. (PMID: 30314758)
      Sci Rep. 2017 Jul 24;7(1):6236. (PMID: 28740209)
      Rheumatology (Oxford). 2007 Oct;46(10):1525-30. (PMID: 17586862)
      Sci Adv. 2020 May 06;6(19):eaaz0571. (PMID: 32494707)
      Science. 2015 Oct 16;350(6258):334-9. (PMID: 26472910)
      Nature. 2015 Feb 19;518(7539):337-43. (PMID: 25363779)
      PLoS One. 2013;8(1):e54359. (PMID: 23382893)
      Nat Genet. 2015 Dec;47(12):1457-1464. (PMID: 26502338)
      Nature. 2011 May 5;473(7345):43-9. (PMID: 21441907)
      Cold Spring Harb Perspect Biol. 2012 Jun 01;4(6):. (PMID: 22661634)
      Science. 2012 Sep 7;337(6099):1190-5. (PMID: 22955828)
      J Mol Med (Berl). 2000;78(9):483-94. (PMID: 11140374)
      Nat Rev Rheumatol. 2009 Jun;5(6):325-31. (PMID: 19434074)
      Front Immunol. 2019 Jan 31;10:43. (PMID: 30804926)
      Genes (Basel). 2018 Jul 27;9(8):. (PMID: 30060490)
      J Pediatr. 1982 May;100(5):731-7. (PMID: 7040622)
      Nat Immunol. 2003 Mar;4(3):235-40. (PMID: 12548284)
      J Clin Endocrinol Metab. 2004 Nov;89(11):5862-5. (PMID: 15531553)
      J Allergy Clin Immunol. 2017 Aug;140(2):616-619.e7. (PMID: 28322850)
      Nat Genet. 2019 Oct;51(10):1442-1449. (PMID: 31501517)
      Clin Exp Immunol. 2017 Feb;187(2):185-192. (PMID: 27690369)
      Proc Natl Acad Sci U S A. 2018 May 15;115(20):5265-5270. (PMID: 29712852)
      Immunity. 2001 Nov;15(5):763-74. (PMID: 11728338)
      Nat Genet. 2004 Apr;36(4):337-8. (PMID: 15004560)
      J Immunol. 2003 Oct 1;171(7):3325-31. (PMID: 14500623)
      Eur J Med Res. 2019 Jul 22;24(1):24. (PMID: 31331400)
      Hum Mol Genet. 2017 Mar 1;26(5):1003-1017. (PMID: 28062664)
    • Contributed Indexing:
      Keywords: autoimmunity; genome-wide association studies; immune tolerance; multi-omics; single nucleotide polymorphism; variant-to-gene mapping
    • Publication Date:
      Date Created: 20210503 Date Completed: 20210916 Latest Revision: 20210916
    • Publication Date:
      20231215
    • Accession Number:
      PMC8082446
    • Accession Number:
      10.3389/fimmu.2021.633219
    • Accession Number:
      33936046